This inventor holds 1 USPTO granted patent. Top assignees: New York University, Pfizer Corporation. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,728 
1 out of 4,488 
Years Active: 2019
Title: An Exploration of Inventor Kristen Leigh Johnson's Contributions
Introduction
Kristen Leigh Johnson is a notable inventor based in New York, NY, who has made significant strides in the field of biotechnology. With a focus on innovative therapeutic solutions, she has been awarded a patent for her research on FGF23 c-tail fusion proteins. This breakthrough holds promise for advancements in treating conditions related to serum phosphate levels.
Latest Patents
Johnson's most recent patent pertains to the FGF23 c-tail fusion proteins. These proteins are designed to modulate serum phosphate levels effectively while maintaining stable serum 1, 25 VitD levels. The disclosed patent outlines fusion proteins comprising a FGF-23 c-tail protein fused to a heterologous amino acid sequence, ensuring versatility and efficacy in pharmaceutical compositions. Additionally, the invention includes vectors with the nucleic acids and host cells that harbor these polynucleotides, illustrating a comprehensive approach to biopharmaceutical development.
Career Highlights
Kristen has had a fruitful career, with experience at prestigious institutions such as New York University and Pfizer Corporation. Her work at these establishments has bolstered her expertise in biomedical research and patent development. Throughout her career, she has contributed to significant advancements in therapeutic methodologies as reflected in her patent.
Collaborations
In her journey, Kristen Leigh Johnson has collaborated with several noteworthy colleagues, including Moosa Mohammadi and Regina Goetz. These collaborations have enriched her research capabilities and fostered an environment of innovation in the projects they undertook together.
Conclusion
Kristen Leigh Johnson exemplifies the spirit of innovation in biotechnology through her patent on FGF23 c-tail fusion proteins. Her contributions aim to tackle complex health challenges and enhance treatment options available in the medical field. With a strong foundation in research and strong collaborations, she continues to push the boundaries of scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile